What is the P/E ratio of IntroMedic Co 2024?
The P/E ratio cannot be calculated for IntroMedic Co at the moment.
Access the world's leading financial data and tools
Subscribe for $2 
Overview
Profile
IntroMedic Co stock stock price, forecast, news, chart, split, dividend and analysis IntroMedic Co ariva, IntroMedic Co onvista, IntroMedic Co finanzen.net, IntroMedic Co aktienfinder, IntroMedic Co marketscreener, IntroMedic Co marketwatch, IntroMedic Co bloomberg, IntroMedic Co handelsblatt, IntroMedic Co wiwo, IntroMedic Co forum
150840.KQ
KR7150840007
Price
Price
5,850.00
Today +/-
+0
Today %
+0 %
Ticker150840.KQ
ISINKR7150840007
P
IntroMedic Co stock price
%
Weekly
Details
Price
ⓘOverview
The Quote Chart provides detailed and dynamic insights into the IntroMedic Co stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.
Intraday Feature
The intraday feature provides real-time data, allowing investors to view the IntroMedic Co stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.
Total Return and Relative Price Change
View the total return of the IntroMedic Co stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.
Interpretation and Investment
Utilize the comprehensive data presented in the Quote Chart to analyze IntroMedic Co's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.
IntroMedic Co Stock Price History
| Date | IntroMedic Co Price |
|---|---|
| 11/12/2024 | 5,850.00 undefined |
| 11/11/2024 | 5,850.00 undefined |
| 11/8/2024 | 5,850.00 undefined |
| 11/7/2024 | 5,850.00 undefined |
| 11/6/2024 | 5,850.00 undefined |
| 11/5/2024 | 5,850.00 undefined |
| 11/4/2024 | 5,850.00 undefined |
| 11/1/2024 | 5,850.00 undefined |
| 10/31/2024 | 5,850.00 undefined |
| 10/30/2024 | 5,850.00 undefined |
| 10/29/2024 | 5,850.00 undefined |
| 10/28/2024 | 5,850.00 undefined |
| 10/25/2024 | 5,850.00 undefined |
| 10/24/2024 | 5,850.00 undefined |
| 10/23/2024 | 5,850.00 undefined |
| 10/22/2024 | 5,850.00 undefined |
| 10/21/2024 | 5,850.00 undefined |
| 10/18/2024 | 5,850.00 undefined |
IntroMedic Co Revenue, EBIT, Net Income KR7150840007 ·
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into IntroMedic Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by IntroMedic Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects IntroMedic Co’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of IntroMedic Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into IntroMedic Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing IntroMedic Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on IntroMedic Co’s growth potential.
IntroMedic Co Revenue, EBIT and net profit per share
| Date | IntroMedic Co Revenue | IntroMedic Co EBIT | IntroMedic Co Net Income |
|---|---|---|---|
| 2023 | 10.16 B undefined | -4.83 B undefined | -6.82 B undefined |
| 2022 | 9.88 B undefined | -3.69 B undefined | -23.27 B undefined |
| 2021 | 7.87 B undefined | -5.23 B undefined | -13.74 B undefined |
| 2020 | 5.96 B undefined | -5.13 B undefined | -7.22 B undefined |
| 2019 | 8.84 B undefined | -5.29 B undefined | -18.94 B undefined |
| 2018 | 9.87 B undefined | -3.24 B undefined | -5.07 B undefined |
| 2017 | 9.01 B undefined | -791 M undefined | -4.11 B undefined |
| 2016 | 8.36 B undefined | -2.66 B undefined | -6.68 B undefined |
| 2015 | 8.26 B undefined | -1.31 B undefined | -874 M undefined |
| 2014 | 10.94 B undefined | 839 M undefined | 1.23 B undefined |
| 2013 | 10.6 B undefined | 2.25 B undefined | 2.35 B undefined |
| 2012 | 8.57 B undefined | 1.46 B undefined | 451 M undefined |
| 2011 | 7.62 B undefined | 513 M undefined | -519 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2011 | 7.62 B KRW | 513 M KRW | -519 M KRW |
| 2012 | 8.57 B KRW | 1.46 B KRW | 451 M KRW |
| 2013 | 10.6 B KRW | 2.25 B KRW | 2.35 B KRW |
| 2014 | 10.94 B KRW | 839 M KRW | 1.23 B KRW |
| 2015 | 8.26 B KRW | -1.31 B KRW | -874 M KRW |
| 2016 | 8.36 B KRW | -2.66 B KRW | -6.68 B KRW |
| 2017 | 9.01 B KRW | -791 M KRW | -4.11 B KRW |
| 2018 | 9.87 B KRW | -3.24 B KRW | -5.07 B KRW |
| 2019 | 8.84 B KRW | -5.29 B KRW | -18.94 B KRW |
| 2020 | 5.96 B KRW | -5.13 B KRW | -7.22 B KRW |
| 2021 | 7.87 B KRW | -5.23 B KRW | -13.74 B KRW |
| 2022 | 9.88 B KRW | -3.69 B KRW | -23.27 B KRW |
| 2023 | 10.16 B KRW | -4.83 B KRW | -6.82 B KRW |
IntroMedic Co Income Statement, Balance Sheet, Cash Flow Statement
Simple
Expanded
Income Statement
Balance Sheet
Cashflow
| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.62 | 8.57 | 10.6 | 10.94 | 8.26 | 8.36 | 9.01 | 9.87 | 8.84 | 5.96 | 7.87 | 9.88 | 10.16 |
| - | 12.42 | 23.74 | 3.20 | -24.51 | 1.26 | 7.71 | 9.60 | -10.51 | -32.51 | 31.98 | 25.51 | 2.82 |
| 71.71 | 75.04 | 77.67 | 73.62 | 70.16 | 63.95 | 62.02 | 59.21 | 63.52 | 53.11 | 58.14 | 67.18 | 62.76 |
| 5.47 | 6.43 | 8.24 | 8.06 | 5.8 | 5.35 | 5.59 | 5.85 | 5.61 | 3.17 | 4.58 | 6.64 | 6.38 |
| -0.52 | 0.45 | 2.35 | 1.23 | -0.87 | -6.68 | -4.11 | -5.07 | -18.94 | -7.22 | -13.74 | -23.27 | -6.82 |
| - | -186.90 | 421.95 | -47.92 | -171.29 | 663.96 | -38.45 | 23.24 | 273.88 | -61.85 | 90.21 | 69.31 | -70.70 |
| 7 | 7 | 11 | 14 | 14 | 14 | 14 | 15 | 21 | 28 | 35.32 | 38.23 | 38.25 |
| - | - | - | - | - | - | - | - | - | - | - | - | - |
Details
Keystats
ⓘRevenue and Growth
The IntroMedic Co Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.
Gross Margin
The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.
EBIT and EBIT Margin
EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.
Income and Growth
Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.
Shares Outstanding
Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.
Interpreting Year to Year Comparison
Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.
Expectations and Predictions
Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the IntroMedic Co is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.
IntroMedic Co stock margins KR7150840007 ·
The IntroMedic Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of IntroMedic Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for IntroMedic Co.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the IntroMedic Co's sales revenue. A higher gross margin percentage indicates that the IntroMedic Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the IntroMedic Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the IntroMedic Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the IntroMedic Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the IntroMedic Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the IntroMedic Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
IntroMedic Co Margin History
| IntroMedic Co Gross margin | IntroMedic Co Profit margin | IntroMedic Co EBIT margin | IntroMedic Co Profit margin |
|---|---|---|---|
| 2023 | 62.76 % | -47.55 % | -67.11 % |
| 2022 | 67.18 % | -37.37 % | -235.52 % |
| 2021 | 58.15 % | -66.42 % | -174.6 % |
| 2020 | 53.11 % | -85.95 % | -121.15 % |
| 2019 | 63.52 % | -59.91 % | -214.32 % |
| 2018 | 59.21 % | -32.82 % | -51.3 % |
| 2017 | 62.02 % | -8.78 % | -45.62 % |
| 2016 | 63.95 % | -31.84 % | -79.83 % |
| 2015 | 70.16 % | -15.84 % | -10.58 % |
| 2014 | 73.62 % | 7.67 % | 11.2 % |
| 2013 | 77.67 % | 21.25 % | 22.2 % |
| 2012 | 75.04 % | 17 % | 5.26 % |
| 2011 | 71.71 % | 6.73 % | -6.81 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2011 | 71.71 % | 6.73 % | -6.81 % |
| 2012 | 75.04 % | 17 % | 5.26 % |
| 2013 | 77.67 % | 21.25 % | 22.2 % |
| 2014 | 73.62 % | 7.67 % | 11.2 % |
| 2015 | 70.16 % | -15.84 % | -10.58 % |
| 2016 | 63.95 % | -31.84 % | -79.83 % |
| 2017 | 62.02 % | -8.78 % | -45.62 % |
| 2018 | 59.21 % | -32.82 % | -51.3 % |
| 2019 | 63.52 % | -59.91 % | -214.32 % |
| 2020 | 53.11 % | -85.95 % | -121.15 % |
| 2021 | 58.15 % | -66.42 % | -174.6 % |
| 2022 | 67.18 % | -37.37 % | -235.52 % |
| 2023 | 62.76 % | -47.55 % | -67.11 % |
IntroMedic Co Stock Sales Revenue, EBIT, Earnings per Share KR7150840007 ·
The IntroMedic Co earnings per share therefore indicates how much revenue IntroMedic Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
3 years
5 years
10 years
25 Years
Max
Sales per Share
EBIT per share
Earnings per Share
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue IntroMedic Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates IntroMedic Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of IntroMedic Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating IntroMedic Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
IntroMedic Co Revenue, EBIT and net profit per share
| Date | IntroMedic Co Sales per Share | IntroMedic Co EBIT per share | IntroMedic Co Earnings per Share |
|---|---|---|---|
| 2023 | 265.54 undefined | -126.26 undefined | -178.22 undefined |
| 2022 | 258.36 undefined | -96.54 undefined | -608.5 undefined |
| 2021 | 222.86 undefined | -148.03 undefined | -389.12 undefined |
| 2020 | 212.96 undefined | -183.04 undefined | -258 undefined |
| 2019 | 420.76 undefined | -252.1 undefined | -901.76 undefined |
| 2018 | 658.27 undefined | -216.07 undefined | -337.67 undefined |
| 2017 | 643.5 undefined | -56.5 undefined | -293.57 undefined |
| 2016 | 597.43 undefined | -190.21 undefined | -476.93 undefined |
| 2015 | 590 undefined | -93.43 undefined | -62.43 undefined |
| 2014 | 781.57 undefined | 59.93 undefined | 87.57 undefined |
| 2013 | 963.91 undefined | 204.82 undefined | 214 undefined |
| 2012 | 1,224.14 undefined | 208.14 undefined | 64.43 undefined |
| 2011 | 1,088.86 undefined | 73.29 undefined | -74.14 undefined |
| Sales per Share | EBIT per share | Earnings per Share | |
|---|---|---|---|
| 2011 | 1,088.86 KRW | 73.29 KRW | -74.14 KRW |
| 2012 | 1,224.14 KRW | 208.14 KRW | 64.43 KRW |
| 2013 | 963.91 KRW | 204.82 KRW | 214 KRW |
| 2014 | 781.57 KRW | 59.93 KRW | 87.57 KRW |
| 2015 | 590 KRW | -93.43 KRW | -62.43 KRW |
| 2016 | 597.43 KRW | -190.21 KRW | -476.93 KRW |
| 2017 | 643.5 KRW | -56.5 KRW | -293.57 KRW |
| 2018 | 658.27 KRW | -216.07 KRW | -337.67 KRW |
| 2019 | 420.76 KRW | -252.1 KRW | -901.76 KRW |
| 2020 | 212.96 KRW | -183.04 KRW | -258 KRW |
| 2021 | 222.86 KRW | -148.03 KRW | -389.12 KRW |
| 2022 | 258.36 KRW | -96.54 KRW | -608.5 KRW |
| 2023 | 265.54 KRW | -126.26 KRW | -178.22 KRW |
IntroMedic Co business model
IntroMedic Co is one of the most popular companies on Eulerpool.com.
IntroMedic Co Eulerpool Fair Value
Details
Fair Value
ⓘUnderstanding Fair Value
The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.
Income-Based Fair Value
This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.
Example 2022
Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)
Revenue-Based Fair Value
It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.
Example 2022
Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)
Dividend-Based Fair Value
This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.
Example 2022
Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)
Expectations and Forecasts
Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.
Comparative Analysis
Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.
IntroMedic Co historical P/E ratio, EBIT multiple, and P/S ratio
IntroMedic Co shares outstanding KR7150840007 ·
The number of shares was IntroMedic Co in 2023 — This indicates how many shares 38.254 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue IntroMedic Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates IntroMedic Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of IntroMedic Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating IntroMedic Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2011 | 7 M Aktien |
| 2012 | 7 M Aktien |
| 2013 | 11 M Aktien |
| 2014 | 14 M Aktien |
| 2015 | 14 M Aktien |
| 2016 | 14 M Aktien |
| 2017 | 14 M Aktien |
| 2018 | 15 M Aktien |
| 2019 | 21 M Aktien |
| 2020 | 28 M Aktien |
| 2021 | 35.32 M Aktien |
| 2022 | 38.23 M Aktien |
| 2023 | 38.25 M Aktien |
IntroMedic Co stock splits
In IntroMedic Co's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for IntroMedic Co.
IntroMedic Co shareholders
% | Name | Stocks | Change | Date |
|---|---|---|---|---|
| 9.80667 % | Fort Hamilton Investment Fund | 4,216,867 | 0 | 3/31/2024 |
| 2.80190 % | Cross Il Sasam Holdings Co., Ltd. | 1,204,819 | 0 | 3/31/2024 |
1
Most common questions regarding IntroMedic Co
What is the P/S ratio of IntroMedic Co 2024?
The P/S cannot be calculated for IntroMedic Co currently.
What is the Quality Investing of IntroMedic Co?
The Quality Investing for IntroMedic Co is 2/10.
What is the revenue of IntroMedic Co 2024?
The revenue cannot currently be calculated for IntroMedic Co.
How high is the profit of IntroMedic Co 2024?
The profit cannot currently be calculated for IntroMedic Co.
What is the business model of IntroMedic Co
No history available for IntroMedic Co.
What is the IntroMedic Co dividend?
IntroMedic Co pays a dividend of 0 KRW distributed over payouts per year.
How often does IntroMedic Co pay dividends?
The dividend cannot currently be calculated for IntroMedic Co or the company does not pay out a dividend.
What is the IntroMedic Co ISIN?
The ISIN of IntroMedic Co is KR7150840007.
What is the IntroMedic Co ticker?
The ticker of IntroMedic Co is 150840.KQ.
How much dividend does IntroMedic Co pay?
Over the past 12 months, IntroMedic Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, IntroMedic Co is expected to pay a dividend of 0 KRW.
What is the dividend yield of IntroMedic Co?
The current dividend yield of IntroMedic Co is .
When does IntroMedic Co pay dividends?
IntroMedic Co pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of IntroMedic Co?
IntroMedic Co paid dividends every year for the past 0 years.
What is the dividend of IntroMedic Co?
For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.
In which sector is IntroMedic Co located?
IntroMedic Co is assigned to the 'Health' sector.
Wann musste ich die Aktien von IntroMedic Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of IntroMedic Co from 11/16/2024 amounting to 0 KRW, you needed to have the stock in your portfolio before the ex-date on 11/16/2024.
When did IntroMedic Co pay the last dividend?
The last dividend was paid out on 11/16/2024.
What was the dividend of IntroMedic Co in the year 2023?
In the year 2023, IntroMedic Co distributed 0 KRW as dividends.
In which currency does IntroMedic Co pay out the dividend?
The dividends of IntroMedic Co are distributed in KRW.
IntroMedic Co stock
Sector
Health
Industry
Health Care Equipment
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website IntroMedic Co
Country
South Korea 🇰🇷
Currency
KRW
Initial public offering
Dec 19, 2013
GOSIN
Global Open Securities Identification Number
Cusip
Y41539100
Market capitalization
Quality Investing
2 / 10Details
PEG
0
P/E ratio
Forward P/E ratio
0
P/S ratio
Forward P/S ratio
0
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
IntroMedic Co Peer Group
IntroMedic Co Eulerpool News
IntroMedic Co News
IntroMedic Co FIGI
| IntroMedic Co Ticker | IntroMedic Co FIGI |
|---|---|
| 150840:KS | BBG005KPTJ52 |
| 150840:KQ | BBG005KPTJ70 |
All fundamentals about IntroMedic Co
Our stock analysis for IntroMedic Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of IntroMedic Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- IntroMedic Co Revenue
- IntroMedic Co Net Income
- IntroMedic Co P/E
- IntroMedic Co P/S
- IntroMedic Co EBIT
- IntroMedic Co Dividend
- IntroMedic Co Stocks
- IntroMedic Co Market capitalization
- IntroMedic Co Debt
- IntroMedic Co Liabilities
- IntroMedic Co Equity
- IntroMedic Co AAQS
- IntroMedic Co Employees
- IntroMedic Co ROE
- IntroMedic Co ROA
- IntroMedic Co ROCE